RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance (NMR) technology, today announced publication of a clinical study in the Journal of Clinical Lipidology demonstrating that in many people, low density lipoprotein (LDL) cholesterol (“bad” cholesterol) is a less accurate predictor of cardiovascular disease (CVD) events than LDL particle number.
